| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP & Bu Lead - Molecular | See Remarks | See Remarks
1 company
Brian Smith last filed a Form 4 in February 2018, as EVP & Bu Lead - Molecular at OSUR. Brian Smith's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 18,075 shares of OSUR. The OSUR filings lean toward selling, a net 32,187 shares.
Brian Smith has 4 Form 4 filings on record from August 2017 to February 2018, all as EVP & Bu Lead - Molecular at Orasure Technologies (OSUR), 2017–2018.
The 11 reported transactions were 6 open-market sales, 3 option exercises and 2 tax withholdings.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $611K.
The largest open-market sale was 20,000 shares of OSUR at an average $17.97 on February 16, 2018, about $359K.
Shares as reported in the last Form 4 for each company; the most recent is from February 2018. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2018 | OSUR Orasure Technologies Inc | EVP & Bu Lead - Molecular | Sale+OE | 20,000 | $17.97 | $359,460.00 | -52.5% | |
| Aug 31, 2017 | OSUR Orasure Technologies Inc | See Remarks | Sale+OE | 9,112 | $20.47 | $186,515.64 | -28.1% | |
| Aug 22, 2017 | OSUR Orasure Technologies Inc | See Remarks | Sell | 3,075 | $21.09 | $64,864.00 | -11.6% |